5 assets in Pure Autonomic Failure

Therapeutic assets addressing Pure Autonomic Failure, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Droxidopa Pure Autonomic Failure	Vanderbilt University Medical Center	P3	BB (68)
Midodrine Pure Autonomic Failure	Vanderbilt University Medical Center	P1	CCC (53)
Carbidopa Pure Autonomic Failure	Daniel Claassen	P1	CC (43)
Entacapone Pure Autonomic Failure	Daniel Claassen	P1	CC (43)
FDOPA Pure Autonomic Failure	Daniel Claassen	P1	CC (43)